Free Newsletter
Solid dosage guide released
ISPE has released Oral Solid Dosage (OSD) Forms Baseline Guide, Second Edition, at its annual meeting in San Diego this week. The FDA-reviewed publication updates content from the original work to current industry standards, practices, and regulatory requirements.
The not-for-profit association says the guide addresses the latest interpretation of GMP requirements, as well as a risk-based approach to regulatory compliance related to the design, construction, and validation of solid dosage manufacturing facilities. A non-theoretical approach gives readers guidance on solving problems and addressing regulatory inspections and compliance issues.
Topics include regulatory philosophy, product protection, process support and utilities, risk-based approaches to commissioning and qualification, and cost factors in oral solid dose manufacturing.
- here's the table of contents
Related Article:
GMP deviators keep paying
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
